American College of Cardiology

Heart Valve Summit 2008
Case-Based Solutions: Medical and Surgical Management

Program Directors: David H. Adams, MD, FACC and Robert O. Bonow, MD, MACC
Program Co-Directors: Patrick M. McCarthy, MD, FACC and Pravin Shah, MD, MACC

September 18 - 20, 2008
The Blackstone, A Renaissance Hotel
Chicago, Illinois

PROGRAM OVERVIEW
Statement of Need
Valvular heart disease remains a significant cause of cardiovascular morbidity and mortality. Management of patients with valvular disease is particularly challenging because, unlike other types of cardiovascular disease, there is a scarcity of large-scale multi-center trials addressing optimal treatment in a variety of complex scenarios.  Now the introduction of newer diagnostic modalities and the developing option of percutaneous therapy offer new dilemmas, new promise and new opportunities to improve patient care.

Overview
This two-and-a-half day program offers an in-depth and interactive look at medical, imaging and surgical challenges in valvular heart disease. Drawing on the ACC/AHA Guidelines annual review and building on the success of previous programs, the 2008 Heart Valve Summit offers up-to-date and clinically relevant information on future directions in valvular heart disease. The format includes case-based patient management discussions and debates with experts in the field; break-out sessions; and poster presentations featuring original research from early career physicians, physician assistants and advanced practice nurse members of the cardiac care team.

Geared toward practicing clinicians across multiple disciplines, this exciting summit will address:

• Surgical and percutaneous therapies for valvular heart disease
• Multi-modality imaging in valvular heart disease (echo, intra-operative TEE, CT and MRI)
• Controversies and solutions in patient management, including choice of valve prosthesis, anticoagulation, antibiotic prophylaxis; concomitant valve and revascularization surgery; hybrid percutaneous coronary revascularization and valve surgery; the use of statins for bioprosthetic and degenerative valve disease
• Practice management and patient education models for nurses and other non-physician members of the cardiac care team

New this year – Submit your challenging cases to the experts before the conference. The top cases will be presented at the conference!  Click here for more information.

Learner Objectives
Upon completion of this program, attendees should be able to —

• Describe advances in non-invasive imaging in the assessment of patients with valvular heart disease
• Recognize advances in aortic valve evaluation and treatment options
• Identify when to refer patients for surgery, particularly valve repair surgery
• Discuss surgical indications, techniques and outcomes for valve repair and replacement surgery
• Evaluate controversial issues in the management of patients with valvular heart disease and the limitations imposed by the lack of randomized controlled trials in this area
• Discuss advances in percutaneous interventional therapies for aortic and mitral valve disease
• Summarize management strategies for patients with valvular heart disease

FACULTY
Program Directors
David H. Adams, MD, FACC
Chair of Cardiothoracic Surgery
Marie-Josee and Henry R. Kravis Professor
Mount Sinai School of Medicine
New York, NY

Robert O. Bonow, MD, MACC
Chief, Division of Cardiology
Northwestern University Medical School
Northwestern Memorial Hospital
Chicago, IL

Program Co-Directors
Patrick M. McCarthy, MD, FACC
Chief, Cardiothoracic Surgery
Bluhm Cardiovascular Institute
Northwestern Memorial Hospital
Chicago, IL

Pravin Shah, MD, MACC
Medical Director
Hoag Heart Institute
Newport Beach, CA

Nurse Planner
Michele Langenfeld, RN, MS
Administrator, Education and Outreach
Bluhm Cardiovascular Institute
Northwestern Memorial Hospital
Chicago, IL

Invited Faculty
Jefffrey S. Borer, MD, FACC
Chief, Division of Cardiovascular Pathophysiology
New York Presbyterian Hospital
Weill Cornell Medical Center
New York, NY

Blase Anthony Carabello, MD, FACC
Professor of Medicine
Baylor College of Medicine
Houston, TX

W. Randolph Chitwood, MD, FACC
Senior Associate Vice-Chancellor of Health Sciences
Director, East Carolina Heart Institute
East Carolina University
Greenville, NC

Ted Feldman, MD, FACC
Evanston Northwestern Healthcare
Cardiology Division
Evanston, IL

Gregory W. Fischer, MD
Assistant Professor
Anesthesiology and Cardiothoracic Surgery
Mount Sinai Medical Center
New York, NY

Jane Kruse, RN, BSN
Clinical Nurse
Northwestern Memorial Hospital
Chicago, IL

Roberto R. Lang, MD, FACC, FASE
Professor of Medicine
University of Chicago Medical Center
Chicago, IL

Martin B. Leon, MD, FACC
Director and CEO
Cardiovascular Research Foundation
New York, NY

Michael Mack, MD
Director, Cardiopulmonary Research Science Technology Institute
Medical City Dallas
Dallas, TX

Randolph P. Martin, MD, FACC, FASE
Director Noninvasive Cardiology
Professor of Medicine
Emory University School of Medicine
Atlanta, GA

Patrick T. O'Gara, MD, FACC
Associate Professor of Medicine
Harvard Medical School
Director, Clinical Cardiology
Brigham and Women's Hospital
Boston, MA

Jennifer O'Leary, RN, BSN
Clinical Nurse
Northwestern Memorial Hospital
Chicago, IL

Nalini M. Rajamannan, MD, FACC
Associate Professor of Medicine
Northwestern University
Chicago, IL

Melissa Shryock, PA, RN
Physician Assistant
Northwestern Memorial Hospital
Chicago, IL

Paul Stelzer, MD, FACC
Department of Cardiothoracic Surgery
Mount Sinai School of Medicine
New York, NY

Julie A. Swain, MD, FACS
Special Assistant to the Director
Division of Cardiovascular and Respiratory Devices
Food and Drug Administration
Office of Device Evaluation
Fallbrook, CA

Melanie Turner, BSN, RNBC
Clinical Nurse
University of Virginia Medical Center
Charlottesville, VA

Susan Underwood, RN, BSN
Nurse Clinician
Bluhm Cardiovascular Institute
Chicago, IL

Bram D. Zuckerman, MD, FACC
Dirctor, Division of Cardiovascular Devices
Food and Drug Administration
Center for Devices and Radiological Health
Rockville, MD

DISCLOSURES
ACCF faculty, committee members, staff and other individuals who are in a position to control the content of this activity are required to disclose all real or apparent conflicts of interest.  All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, patient care and safety recommendations.  ACCF staff involved with this program have nothing to disclose. Refer to the links below for committee members and faculty disclosures.

ACC Live Programs Committee (2007-2010) disclosures

AGENDA
Click here for agenda.

TARGET AUDIENCE
This program is intended for cardiologists, cardiothoracic surgeons, cardiac anesthesiologists, internists, physician assistants, nurse practitioners, registered nurses, sonographers, pharmacists, perfusionists and other medical professionals involved in the evaluation, diagnosis and/or management of patients with valvular heart disease.

ACCREDITATION
Physicians
The American College of Cardiology Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ACCF designates this educational activity for a maximum of 19.25 AMA PRA Category 1 Credits™.  Physicians should only claim credits commensurate with the extent of their participation in the activity.

Nurses
The American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The ACCF designates this educational activity for a maximum of 19.25 continuing education hours.  Each attendee should only claim credits commensurate with the extent of their participation in the activity.

REGISTRATION
To Register On Line for the Program click here.

To Register by Fax, Email or Phone for the Program click here.

Please note that if you are a member of ASE or STS (and you are not an ACC Member), you must submit your registration form through fax or mail to receive the member rate.

ACCOMMODATIONS
Location
All sessions will be held at The Blackstone, A Renaissance Hotel, 636 S. Michigan Avenue, Chicago, Illinois.  The hotel telephone number is (312) 447-0955.

Accommodations
To reserve your room at The Blackstone, A Renaissance Hotel, please call The Global Reservations Center at (800) 228-9290 or fax your reservation to (312) 765-0545. Identify yourself as a participant in the American College of Cardiology Foundation (ACCF) program – Heart Valve Summit.

Room Rates
The room rate is $279 plus 15.4% state tax (subject to change) per night for single or double occupancy. The hotel room block is scheduled to be held until August 19, 2008, but may sell out prior to this date. We advise you to register for the program and reserve your lodging as soon as possible. When you make your reservation, please be sure to ask about early departure fees or cancellation penalties.

GENERAL INFORMATION
Tuition
The registration tuition includes continental breakfasts, refreshment breaks, lunches and the syllabus.

Cancellations
Cancellation, substitution or transfer to another course is allowed if written notification is received four weeks before a scheduled course. A full refund minus a $100 processing fee will be given for written notifications received fewer than four weeks before the first day of the program. No refund will be given for no-shows.

In the unlikely event that the program is canceled, the College will refund the registration tuition in full but is not responsible for any travel or hotel costs you may incur.

The ACCF reserves the right to cancel programs in the unlikely event of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the ACCF will refund registration tuition but cannot be held responsible for other costs or expenses, including cancellations/change penalties assessed by airlines, travel agencies or hotels.

Please Note
Smoking is prohibited in all ACCF meeting rooms.

Videotaping, audiotaping and still photography are prohibited in all ACCF meeting rooms.

We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us serve you better.

Faculty and program are subject to change without notice. The views expressed in this program are those of the individual speaker and do not necessarily reflect views of the ACCF.

Case Submissions
Stump the Experts! Challenging cases can be submitted to the Heart Valve Summit faculty prior to the conference. Five to ten cases will be chosen based on appropriateness of content and will be included in the Saturday morning session. Please send an abstract of the case you wish to submit, including all relevant clinical parameters and history to jsoslow@acc.org. In addition, please send a CD-ROM of the imaging available to Jane Soslow, 721 Live Oak Street, Metairie, LA 70005. You will be notified prior to the conference whether your case has been chosen. You must be registered for the conference to have your case reviewed for inclusion in the conference. If you have any questions, please call us at (800) 253-4636, ext. 6518.  

Each case presenter will be asked to comply with the ACCF “Statement of Disclosure on Disclosure (vested interest) and Conflict of Interest for Accredited Activities” Policy.  Indication of the relationship, the associated commercial entity and level of support is required for each presenter. Disclosure information must be submitted with the abstract.  Click here to download the disclosure form.  Case presenters must display a disclosure statement on their case presentations or that they have nothing to disclose. 

Deadline for case submissions is Monday, June 9, 2008 at 11:59 p.m. EDT.

POSTERS 
Early career practitioners, fellows in training, residents and members of the non-physician cardiac care team are invited to submit abstracts for poster presentations during the 2008 Heart Valve Summit. Research in valvular heart disease and/or best practices in patient management and patient education will be considered.

1. Accepted abstracts will be scheduled during a poster session on Friday, September 19, 2008. Presenters must be present at their posters during the session. Each presentation will be posted on a 4 foot by 8 foot board. Awards will be given on Saturday, September 20, 2008. Award recipients will be expected to give a 5 minute overview of their research.
2. Investigators need not be ACC members to participate.
3. The College is unable to reimburse presenters for travel, hotel and per diem expenses. All accepted abstract presenters will be charged the reduced registration tuition and must register to obtain hotel reservation and meeting badge. Please register in the FIT/CCA categories. Early registration is suggested. 
4. You will be notified of acceptance within two weeks of receipt of the abstract. 

Policies

1. Abstracts must be ELECTRONICALLY SUBMITTED BY 11:59 p.m., CT, FRIDAY, AUGUST 1, 2008.   The American College of Cardiology Foundation (ACCF) is not responsible for abstracts that are not submitted by this deadline date. 
2. Please limit abstracts to 500 characters.     
3. Submissions with incomplete status cannot be processed.
4. Submission of abstract constitutes a commitment by the author(s) to present if accepted. Failure to present and register for the meeting, if not justified, will jeopardize future acceptance of abstracts.
5. There is no limit to the number of abstracts an investigator may submit. If selected, the presenter must be one of the co-authors listed.  An investigator may not present more than one abstract. If more than one abstract is accepted from an investigator, one of the co-authors must present.
6. Follow all the instructions for submission. Be sure to structure the content into Background, Methods, Results and Conclusion sections.
7. Clarity of expression will be considered in the review process. The overall quality of language used should assure comprehension by the reader.
8. Proofread abstracts carefully to avoid errors before they are submitted.  The ACCF is not authorized to make changes to a submission.
9. Each submitter is required to submit a minimum of one (and up to three) learning objective(s) that is specific to the presentation.  Begin each statement of a specific learning outcome with a verb that specifies definite, observable behavior such as “demonstrate”, “identify”, “interpret”, “distinguish”, “describe”, “evaluate”, etc. You will be asked to complete the following sentence: “At the conclusion of this presentation, participants will be able to….”
10. Any human experimentation must conform to the principles of the Declaration of Helsinki of the World Medical Association.
11. The Live Program Committee endorses the position of the American Association for the Advancement of Science in requiring assurances of the responsible use of animals in research. All submissions for consideration must be in compliance with the guidelines.
12. Each presenting author will be asked to comply with the ACCF “Statement of Disclosure on Disclosure (vested interest) and Conflict of Interest for Accredited Activities” Policy. Indication of the relationship, the associated commercial entity and level of support is required for each author.  Disclosure information must be submitted with the abstract. Click here to download the disclosure form. Presenters must display a disclosure statement on their presentations or that they have nothing to disclose.

Poster Presentations

1. Each poster board measures four feet high (121 cm) and eight feet wide (244 cm). 
2. You must provide a copy of the abstract, typed in large type for posting on the board. 
3. Poster presentation should be divided into Background, Methods, Results and Conclusion sections.
4. Illustrations must be readable from a distance of at least three feet. 
5. Use lightweight poster board only; heavy poster board is difficult to secure.  Velcro fasteners and push pins will be available on site. 
6. All presentation materials should be made in advance and brought to the meeting.
7. No audiovisual, projection, or computer equipment requiring electrical power will be permitted in the poster session area.

Click here to submit your abstract.

ACKNOWLEDGMENTS
Appreciation is expressed to

for their program support.

At the time of printing, a complete listing of industry supporters was not available. Appropriate acknowledgment will be updated upon confirmation of support and at the time of the program.